{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:25:57Z","timestamp":1790011557021,"version":"4.0.1"},"reference-count":161,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec><jats:title\/><jats:p>Quinoline derivatives are considered broad-spectrum pharmacological compounds that exhibit a wide range of biological activities. Integration of quinoline moiety can improve its physical and chemical properties and also pharmacological behavior. Due to its wide range of pharmaceutical applications, it is a very popular compound to design new drugs for the treatment of multiple diseases like cancer, dengue fever, malaria, tuberculosis, fungal infections, AIDS, Alzheimer\u2019s disease and diabetes. In this review, our major focus is to pay attention to the biological activities of quinoline compounds in the treatment of these diseases such as anti-viral, anti-cancer, anti-malarial, antibacterial, anti-fungal, anti-tubercular and anti-diabetic.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389557520999201214234735","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T10:54:09Z","timestamp":1608029649000},"page":"1152-1172","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Current Pharmaceutical Aspects of Synthetic Quinoline Derivatives"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9483-254X","authenticated-orcid":true,"given":"Rukhsana","family":"Tabassum","sequence":"first","affiliation":[{"name":"Department of Chemistry, The Islamia University of Bahawalpur, Bahawalpur, 36100,Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ashfaq","sequence":"additional","affiliation":[{"name":"Department of Chemistry, The Islamia University of Bahawalpur, Bahawalpur, 36100,Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Oku","sequence":"additional","affiliation":[{"name":"Division of Molecular Science, Graduate School of Science &amp; Engineering Gunma University, Gunma 376-8515,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1016\/j.bmc.2010.06.094","volume":"18","author":"Zarghi A.","year":"2010","unstructured":"Zarghi A.; Ghodsi R.; Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors. Bioorg Med Chem 2010,18(16),5855-5860","journal-title":"Bioorg Med Chem"},{"key":"ref=2","first-page":"446","volume":"20","author":"Hosseinzadeh H.","year":"2017","unstructured":"Hosseinzadeh H.; Mazaheri F.; Ghodsi R.; Pharmacological effects of a synthetic quinoline, a hybrid of tomoxiprole and naproxen, against acute pain and inflammation in mice: A behavioral and docking study. Iran J Basic Med Sci 2017,20(4),446-450","journal-title":"Iran J Basic Med Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1021\/acsmedchemlett.7b00545","volume":"9","author":"Upadhyay K.D.","year":"2018","unstructured":"Upadhyay K.D.; Dodia N.M.; Khunt R.C.; Chaniara R.S.; Shah A.K.; Synthesis and biological screening of pyrano[3,2-c]quinoline analogues as anti-inflammatory and anticancer agents. ACS Med Chem Lett 2018,9(3),283-288","journal-title":"ACS Med Chem Lett"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.2174\/138955709791012247","volume":"9","author":"Kumar S.","year":"2009","unstructured":"Kumar S.; Bawa S.; Gupta H.; Biological activities of quinoline derivatives. Mini Rev Med Chem 2009,9(14),1648-1654","journal-title":"Mini Rev Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejmech.2017.07.061","volume":"139","author":"Hu Y-Q.","year":"2017","unstructured":"Hu Y-Q.; Gao C.; Zhang S.; Xu L.; Xu Z.; Feng L-S.; Wu X.; Zhao F.; Quinoline hybrids and their antiplasmodial and antimalarial activities. Eur J Med Chem 2017,139,22-47","journal-title":"Eur J Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2018.01.039","volume":"146","author":"Fan Y-L.","year":"2018","unstructured":"Fan Y-L.; Cheng X-W.; Wu J-B.; Liu M.; Zhang F-Z.; Xu Z.; Feng L-S.; Antiplasmodial and antimalarial activities of quinolone derivatives: An overview. Eur J Med Chem 2018,146,1-14","journal-title":"Eur J Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ejmech.2010.12.003","volume":"46","author":"Kumar A.","year":"2011","unstructured":"Kumar A.; Srivastava K.; Kumar S.R.; Siddiqi M.I.; Puri S.K.; Sexana J.K.; Chauhan P.M.S.; 4-anilinoquinoline triazines: A novel class of hybrid antimalarial agents. Eur J Med Chem 2011,46(2),676-690","journal-title":"Eur J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/1389557514666140220123226","volume":"14","author":"Gryz\u0142o B.","year":"2014","unstructured":"Gryz\u0142o B.; Kulig K.; Quinoline \u2013\u2013 a promising fragment in the search for new antimalarials. Mini Rev Med Chem 2014,14(4),332-344","journal-title":"Mini Rev Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1007\/s00044-014-1048-3","volume":"23","author":"Gaurav A.","year":"2014","unstructured":"Gaurav A.; Singh R.; Pharmacophore modeling, 3DQSAR, and docking-based design of polysubstituted quinolines derivatives as inhibitors of phosphodiesterase 4, and preliminary evaluation of their anti-asthmatic potential. Med Chem Res 2014,23,5008-5030","journal-title":"Med Chem Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejmech.2016.02.069","volume":"114","author":"Shobeiri N.","year":"2016","unstructured":"Shobeiri N.; Rashedi M.; Mosaffa F.; Zarghi A.; Ghandadi M.; Ghasemi A.; Ghodsi R.; Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors. Eur J Med Chem 2016,114,14-23","journal-title":"Eur J Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ejmech.2014.07.044","volume":"97","author":"Afzal O.","year":"2015","unstructured":"Afzal O.; Kumar S.; Haider M.R.; Ali M.R.; Kumar R.; Jaggi M.; Bawa S.; A review on anticancer potential of bioactive heterocycle quinoline. Eur J Med Chem 2015,97,871-910","journal-title":"Eur J Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.2174\/15680266113139990133","volume":"13","author":"Sharma P.C.","year":"2013","unstructured":"Sharma P.C.; Chaudhary M.; Sharma A.; Piplani M.; Rajak H.; Prakash O.; Insight view on possible role of fluoroquinolones in cancer therapy. Curr Top Med Chem 2013,13(16),2076-2096","journal-title":"Curr Top Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.2174\/1389557519666190312152358","volume":"19","author":"Liu J.C.","year":"2019","unstructured":"Liu J.C.; Narva S.; Zhou K.; Zhang W.; A review on the antitumor activity of various nitrogenous-based heterocyclic compounds as NSCLC inhibitors. Mini Rev Med Chem 2019,19(18),1517-1530","journal-title":"Mini Rev Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.2174\/1389557517666170510104954","volume":"17","author":"Sharma V.","year":"2017","unstructured":"Sharma V.; Mehta D.K.; Das R.; Synthetic methods of quinoline derivatives as potent anticancer agents. Mini Rev Med Chem 2017,17(16),1557-1572","journal-title":"Mini Rev Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2174\/1389557516666151217122758","volume":"16","author":"Patil S.A.","year":"2016","unstructured":"Patil S.A.; Patil S.A.; Patil R.; Hashizume R.; Imidazoquinolines: Recent developments in anticancer activity. Mini Rev Med Chem 2016,16(4),309-322","journal-title":"Mini Rev Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/00005344-199910000-00008","volume":"34","author":"Ebisu H.","year":"1999","unstructured":"Ebisu H.; Nishikawa M.; Tanaka M.; Okazoe T.; Morizawa Y.; Shinyama H.; Nakamura N.; Pharmacologic profiles of GA0113, a novel quinoline derivative angiotensin II AT1-receptor antagonist. J Cardiovasc Pharmacol 1999,34(4),526-532","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.ejmech.2017.10.046","volume":"143","author":"El Shehry M.F.","year":"2018","unstructured":"El Shehry M.F.; Ghorab M.M.; Abbas S.Y.; Fayed E.A.; Shedid S.A.; Ammar Y.A.; Quinoline derivatives bearing pyrazole moiety: Synthesis and biological evaluation as possible antibacterial and antifungal agents. Eur J Med Chem 2018,143,1463-1473","journal-title":"Eur J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1021\/jm0100335","volume":"44","author":"Chen Y-L.","year":"2001","unstructured":"Chen Y-L.; Fang K-C.; Sheu J-Y.; Hsu S-L.; Tzeng C-C.; Synthesis and antibacterial evaluation of certain quinolone derivatives. J Med Chem 2001,44(14),2374-2377","journal-title":"J Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ejmech.2017.11.082","volume":"143","author":"Zhang G-F.","year":"2018","unstructured":"Zhang G-F.; Zhang S.; Pan B.; Liu X.; Feng L-S.; 4-Quinolone derivatives and their activities against gram positive pathogens. Eur J Med Chem 2018,143,710-723","journal-title":"Eur J Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2174\/1389557517666170412112619","volume":"18","author":"Prasad A.S.G.","year":"2018","unstructured":"Prasad A.S.G.; Rao T.B.; Rambabu D.; Rao M.V.B.; Pal M.; Ultrasound assisted synthesis of quinoline derivatives in the presence of SnCl2\u20222H2O as a precatalyst in water: Evaluation of their antibacterial activities. Mini Rev Med Chem 2018,18(10),895-903","journal-title":"Mini Rev Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.2174\/1389557516666160609075620","volume":"16","author":"Desai N.","year":"2016","unstructured":"Desai N.; Trivedi A.; Pandit U.; Dodiya A.; Rao V.K.; Desai P.; Hybrid bioactive heterocycles as potential antimicrobial agents: A review. Mini Rev Med Chem 2016,16(18),1500-1526","journal-title":"Mini Rev Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1021\/jm00040a003","volume":"37","author":"Maguire M.P.","year":"1994","unstructured":"Maguire M.P.; Sheets K.R.; McVety K.; Spada A.P.; Zilberstein A.; A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives. J Med Chem 1994,37(14),2129-2137","journal-title":"J Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ejmech.2017.07.059","volume":"139","author":"Xu Z.","year":"2017","unstructured":"Xu Z.; Gao C.; Ren Q-C.; Song X-F.; Feng L-S.; Lv Z-S.; Recent advances of pyrazole-containing derivatives as anti-tubercular agents. Eur J Med Chem 2017,139,429-440","journal-title":"Eur J Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ejmech.2018.01.080","volume":"146","author":"Fan Y-L.","year":"2018","unstructured":"Fan Y-L.; Wu J-B.; Cheng X-W.; Zhang F-Z.; Feng L-S.; Fluoroquinolone derivatives and their anti-tubercular activities. Eur J Med Chem 2018,146,554-563","journal-title":"Eur J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cclet.2016.07.032","volume":"28","author":"Xu Z.","year":"2017","unstructured":"Xu Z.; Zhang S.; Gao C.; Fan J.; Zhao F.; Lv Z-S.; Feng L-S.; Isatin hybrids and their anti-tuberculosis activity. Chin Chem Lett 2017,28,159-167","journal-title":"Chin Chem Lett"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.biopha.2014.10.007","volume":"68","author":"Keri R.S.","year":"2014","unstructured":"Keri R.S.; Patil S.A.; Quinoline: A promising antitubercular target. Biomed Pharmacother 2014,68(8),1161-1175","journal-title":"Biomed Pharmacother"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1007\/s00044-015-1432-7","volume":"24","author":"Joshi S.D.","year":"2015","unstructured":"Joshi S.D.; More U.A.; Parkale D.; Aminabhavi T.M.; Gadad A.K.; Nadagouda M.N.; Jawarkar R.; Design, synthesis of quinolinyl Schiff bases and azetidinones as enoyl ACP-reductase inhibitors. Med Chem Res 2015,24,3892-3911","journal-title":"Med Chem Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.2174\/1389557515666150709121153","volume":"15","author":"Patel R.V.","year":"2015","unstructured":"Patel R.V.; Keum Y.S.; Park S.W.; Nitroimidazoles, quinolones and oxazolidinones as fluorine bearing antitubercular clinical candidates. Mini Rev Med Chem 2015,15(14),1174-1186","journal-title":"Mini Rev Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1016\/j.bmcl.2015.06.041","volume":"25","author":"Zhang L.","year":"2015","unstructured":"Zhang L.; Kumar K.V.; Geng R-X.; Zhou C-H.; Design and biological evaluation of novel quinolone-based metronidazole derivatives as potent Cu(2+) mediated DNA-targeting antibacterial agents. Bioorg Med Chem Lett 2015,25(17),3699-3705","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ejmech.2017.03.016","volume":"131","author":"Ram\u00edrez-Prada J.","year":"2017","unstructured":"Ram\u00edrez-Prada J.; Robledo S.M.; V\u00e9lez I.D.; Crespo M.D.P.; Quiroga J.; Abonia R.; Montoya A.; Svetaz L.; Zacchino S.; Insuasty B.; Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents. Eur J Med Chem 2017,131,237-254","journal-title":"Eur J Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2174\/1389557519666181210162003","volume":"19","author":"Anusionwu C.G.","year":"2019","unstructured":"Anusionwu C.G.; Aderibigbe B.A.; Mbianda X.Y.; Hybrid molecules development: A versatile landscape for the control of antifungal drug resistance: A review. Mini Rev Med Chem 2019,19(6),450-464","journal-title":"Mini Rev Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.2174\/1389557516666161226161152","volume":"18","author":"Subhedar D.D.","year":"2018","unstructured":"Subhedar D.D.; Shaikh M.H.; Tupe S.G.; Deshpande M.V.; Khedkar V.M.; Jha P.C.; Shingate B.B.; Facile and solvent-free domino synthesis of new quinolidinyl-2,4- thiazolidinones: Antifungal activity and molecular docking. Mini Rev Med Chem 2018,18(7),622-630","journal-title":"Mini Rev Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3390\/molecules22081352","volume":"22","author":"Channar P.A.","year":"2017","unstructured":"Channar P.A.; Saeed A.; Albericio F.; Larik F.A.; Abbas Q.; Hassan M.; Raza H.; Seo S-Y.; Sulfonamide-linked ciprofloxacin, sulfadiazine and amantadine derivatives as a novel class of inhibitors of Jack bean urease; Synthesis, kinetic mechanism and molecular docking. Molecules 2017,22(8),1352","journal-title":"Molecules"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1021\/acs.jmedchem.7b01417","volume":"61","author":"Wang Z.","year":"2018","unstructured":"Wang Z.; Hu J.; Yang X.; Feng X.; Li X.; Huang L.; Chan A.S.C.; Design, synthesis, and evaluation of orally bioavailable quinoline-indole derivatives as innovative multitarget-directed ligands: Promotion of cell proliferation in the adult murine hippocampus for the treatment of Alzheimer\u2019s disease. J Med Chem 2018,61(5),1871-1894","journal-title":"J Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0960-894X(00)00354-1","volume":"10","author":"Edmont D.","year":"2000","unstructured":"Edmont D.; Rocher R.; Plisson C.; Chenault J.; Synthesis and evaluation of quinoline carboxyguanidines as antidiabetic agents. Bioorg Med Chem Lett 2000,10(16),1831-1834","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.tetlet.2012.10.067","volume":"54","author":"Savegnago L.","year":"2013","unstructured":"Savegnago L.; Vieira A.I.; Seus N.; Goldani B.S.; Castro M.R.; Lenard\u00e3o E.J.; Alves D.; Synthesis and antioxidant properties of novel quinoline\u2013chalcogenium compounds. Tetrahedron Lett 2013,54,40-44","journal-title":"Tetrahedron Lett"},{"key":"ref=37","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/585931","volume":"2013","author":"B\u0142aszczyk A.","year":"2013","unstructured":"B\u0142aszczyk A.; Augustyniak A.; Skolimowski J.; Ethoxyquin: An antioxidant used in animal feed. Int J Food Sci 2013,2013","journal-title":"Int J Food Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2174\/1389557516666160505115634","volume":"16","author":"Oliveri V.","year":"2016","unstructured":"Oliveri V.; Vecchio G.; Glycoconjugates of quinolines: Application in medicinal chemistry. Mini Rev Med Chem 2016,16(15),1185-1194","journal-title":"Mini Rev Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/molecules23030672","volume":"23","author":"de la Guardia C.","year":"2018","unstructured":"de la Guardia C.; Stephens D.E.; Dang H.T.; Quijada M.; Larionov O.V.; Lleonart R.; Antiviral activity of novel quinoline derivatives against dengue virus serotype 2. Molecules 2018,23(3),672","journal-title":"Molecules"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/jmv.25440","volume":"91","author":"Han Y.","year":"2019","unstructured":"Han Y.; Pham H.T.; Xu H.; Quan Y.; Mespl\u00e8de T.; Antimalarial drugs and their metabolites are potent Zika virus inhibitors. J Med Virol 2019,91(7),1182-1190","journal-title":"J Med Virol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1002\/slct.201900873","volume":"4","author":"Kos J.","year":"2019","unstructured":"Kos J.; Ku C.F.; Kapustikova I.; Oravec M.; Zhang H-J.; Jampilek J.; 8-hydroxyquinoline-2-carboxanilides as antiviral agents against avian influenza virus. Chem Select 2019,4,4582-4587","journal-title":"Chem Select"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.dsx.2020.03.011","volume":"14","author":"Singh A.K.","year":"2020","unstructured":"Singh A.K.; Singh A.; Shaikh A.; Singh R.; Misra A.; Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab Syndr 2020,14(3),241-246","journal-title":"Diabetes Metab Syndr"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","volume":"14","author":"Gao J.","year":"2020","unstructured":"Gao J.; Tian Z.; Yang X.; Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020,14(1),72-73","journal-title":"Biosci Trends"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5582\/ddt.2020.01012","volume":"14","author":"Dong L.","year":"2020","unstructured":"Dong L.; Hu S.; Gao J.; Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther 2020,14(1),58-60","journal-title":"Drug Discov Ther"},{"key":"ref=45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105923","volume":"55","author":"Colson P.","year":"2020","unstructured":"Colson P.; Rolain J-M.; Raoult D.; Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents 2020,55(3)","journal-title":"Int J Antimicrob Agents"},{"key":"ref=46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949","volume":"56","author":"Gautret P.","year":"2020","unstructured":"Gautret P.; Lagier J-C.; Parola P.; Hoang V.T.; Meddeb L.; Mailhe M.; Doudier B.; Courjon J.; Giordanengo V.; Vieira V.E.; Tissot Dupont H.; Honor\u00e9 S.; Colson P.; Chabri\u00e8re E.; La Scola B.; Rolain J-M.; Brouqui P.; Raoult D.; Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020,56(1)","journal-title":"Int J Antimicrob Agents"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/hiv.12295","volume":"16","author":"Chauhan A.","year":"2015","unstructured":"Chauhan A.; Tikoo A.; The enigma of the clandestine association between chloroquine and HIV-1 infection. HIV Med 2015,16(10),585-590","journal-title":"HIV Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/cid\/ciaa237","volume":"71","author":"Yao X.","year":"2020","unstructured":"Yao X.; Ye F.; Zhang M.; Cui C.; Huang B.; Niu P.; Liu X.; Zhao L.; Dong E.; Song C.; Zhan S.; Lu R.; Li H.; Tan W.; Liu D.; In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020,71(15),732-739","journal-title":"Clin Infect Dis"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1128\/AAC.01509-08","volume":"53","author":"Keyaerts E.","year":"2009","unstructured":"Keyaerts E.; Li S.; Vijgen L.; Rysman E.; Verbeeck J.; Van Ranst M.; Maes P.; Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrob Agents Chemother 2009,53(8),3416-3421","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"Vincent M.J.","year":"2005","unstructured":"Vincent M.J.; Bergeron E.; Benjannet S.; Erickson B.R.; Rollin P.E.; Ksiazek T.G.; Seidah N.G.; Nichol S.T.; Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2005,2,69","journal-title":"Virol J"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"Wang M.","year":"2020","unstructured":"Wang M.; Cao R.; Zhang L.; Yang X.; Liu J.; Xu M.; Shi Z.; Hu Z.; Zhong W.; Xiao G.; Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020,30(3),269-271","journal-title":"Cell Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.4081\/idr.2020.8543","volume":"12","author":"Nicastri E.","year":"2020","unstructured":"Nicastri E.; Petrosillo N.; Ascoli Bartoli T.; Lepore L.; Mondi A.; Palmieri F.; D\u2019Offizi G.; Marchioni L.; Murachelli S.; Ippolito G.; Antinori A.; National Institute for the Infectious Diseases. \u201cL. Spallanzani\u201d, IRCCS. Recommendations for COVID-19 clinical management. Infect Dis Rep 2020,12(1),8543-8543","journal-title":"Infect Dis Rep"},{"key":"ref=53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111925","volume":"\u2022\u2022\u2022","author":"Li F.","year":"2020","unstructured":"Li F.; Lee E.M.; Sun X.; Wang D.; Tang H.; Zhou G-C.; Design, synthesis and discovery of andrographolide derivatives against Zika virus infection. Eur J Med Chem 2020,\u2022\u2022\u2022","journal-title":"Eur J Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1001\/jama.2017.13505","volume":"318","author":"Fauci A.S.","year":"2017","unstructured":"Fauci A.S.; An HIV vaccine is essential for ending the HIV\/AIDS pandemic. JAMA 2017,318(16),1535-1536","journal-title":"JAMA"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1097\/QAD.0000000000000494","volume":"28","author":"Pham Q.D.","year":"2014","unstructured":"Pham Q.D.; Wilson D.P.; Law M.G.; Kelleher A.D.; Zhang L.; Global burden of transmitted HIV drug resistance and HIV-exposure categories: A systematic review and meta-analysis. AIDS 2014,28(18),2751-2762","journal-title":"AIDS"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1016\/j.bmc.2019.06.044","volume":"27","author":"Overacker R.D.","year":"2019","unstructured":"Overacker R.D.; Banerjee S.; Neuhaus G.F.; Milicevic Sephton S.; Herrmann A.; Strother J.A.; Brack-Werner R.; Blakemore P.R.; Loesgen S.; Biological evaluation of molecules of the azaBINOL class as antiviral agents: Inhibition of HIV-1 RNase H activity by 7-isopropoxy-8-(naphth-1-yl)quinoline. Bioorg Med Chem 2019,27(16),3595-3604","journal-title":"Bioorg Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/v11030274","volume":"11","author":"Salata C.","year":"2019","unstructured":"Salata C.; Calistri A.; Alvisi G.; Celestino M.; Parolin C.; Pal\u00f9 G.; Ebola virus entry: From molecular characterization to drug discovery. Viruses 2019,11(3),274","journal-title":"Viruses"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/med.21466","volume":"38","author":"Shang X.F.","year":"2018","unstructured":"Shang X.F.; Morris-Natschke S.L.; Liu Y.Q.; Guo X.; Xu X.S.; Goto M.; Li J.C.; Yang G.Z.; Lee K.H.; Biologically active quinoline and quinazoline alkaloids part I. Med Res Rev 2018,38,775-828","journal-title":"Med Res Rev"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/cmdc.201600441","volume":"12","author":"He C.","year":"2017","unstructured":"He C.; Preiss L.; Wang B.; Fu L.; Wen H.; Zhang X.; Cui H.; Meier T.; Yin D.; Structural simplification of bedaquiline: The discovery of 3-(4-(N,N-dimethylaminomethyl)phenyl)quinoline-derived antitubercular lead compounds. ChemMedChem 2017,12(2),106-119","journal-title":"ChemMedChem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/v10120678","volume":"10","author":"Cui Q.","year":"2018","unstructured":"Cui Q.; Cheng H.; Xiong R.; Zhang G.; Du R.; Anantpadma M.; Davey R.A.; Rong L.; Identification of diaryl-quinoline compounds as entry inhibitors of Ebola virus. Viruses 2018,10(12),678","journal-title":"Viruses"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"Bhatt S.","year":"2013","unstructured":"Bhatt S.; Gething P.W.; Brady O.J.; Messina J.P.; Farlow A.W.; Moyes C.L.; Drake J.M.; Brownstein J.S.; Hoen A.G.; Sankoh O.; Myers M.F.; George D.B.; Jaenisch T.; Wint G.R.W.; Simmons C.P.; Scott T.W.; Farrar J.J.; Hay S.I.; The global distribution and burden of dengue. Nature 2013,496(7446),504-507","journal-title":"Nature"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ejmech.2015.03.053","volume":"95","author":"Zhang G-H.","year":"2015","unstructured":"Zhang G-H.; Xue W-B.; An Y-F.; Yuan J-M.; Qin J-K.; Pan C-X.; Su G-F.; Distinct novel quinazolinone exhibits selective inhibition in MGC-803 cancer cells by dictating mutant p53 function. Eur J Med Chem 2015,95,377-387","journal-title":"Eur J Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ejmech.2015.06.050","volume":"101","author":"Yugandhar D.","year":"2015","unstructured":"Yugandhar D.; Nayak V.L.; Archana S.; Shekar K.C.; Srivastava A.K.; Design, synthesis and anticancer properties of novel oxa\/azaspiro[4,5]trienones as potent apoptosis inducers through mitochondrial disruption. Eur J Med Chem 2015,101,348-357","journal-title":"Eur J Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejmech.2015.04.054","volume":"97","author":"Tseng C-H.","year":"2015","unstructured":"Tseng C-H.; Tzeng C-C.; Hsu C-Y.; Cheng C-M.; Yang C-N.; Chen Y-L.; Discovery of 3-phenylquinolinylchalcone derivatives as potent and selective anticancer agents against breast cancers. Eur J Med Chem 2015,97,306-319","journal-title":"Eur J Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ejmech.2015.12.016","volume":"108","author":"Zhang J.","year":"2016","unstructured":"Zhang J.; Jiang X.; Jiang Y.; Guo M.; Zhang S.; Li J.; He J.; Liu J.; Wang J.; Ouyang L.; Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs. Eur J Med Chem 2016,108,495-504","journal-title":"Eur J Med Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1021\/acs.jmedchem.6b01769","volume":"60","author":"Zhang G-H.","year":"2017","unstructured":"Zhang G-H.; Yuan J-M.; Qian G.; Gu C-X.; Wei K.; Mo D-L.; Qin J-K.; Peng Y.; Zhou Z-P.; Pan C-X.; Su G-F.; Phthalazino[1,2-b]quinazolinones as p53 activators: Cell cycle arrest, apoptotic response and Bak-Bcl-xl complex reorganization in Bladder cancer cells. J Med Chem 2017,60(16),6853-6866","journal-title":"J Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1039\/C5MD00314H","volume":"6","author":"Shrestha J.P.","year":"2015","unstructured":"Shrestha J.P.; Subedi Y.P.; Chen L.; Chang C-W.T.; A mode of action study of cationic anthraquinone analogs: A new class of highly potent anticancer agents. MedChemComm 2015,6,2012-2022","journal-title":"MedChemComm"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1016\/j.tetlet.2016.10.031","volume":"57","author":"Huo C.","year":"2016","unstructured":"Huo C.; Chen F.; Quan Z.; Dong J.; Wang Y.; Cobalt-catalyzed aerobic oxidative Povarov reaction of tertiary anilines with dihydrofuran for the synthesis of hexahydrofuroquinolines. Tetrahedron Lett 2016,57,5127-5131","journal-title":"Tetrahedron Lett"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1381612805666230109215114","volume":"5","author":"Gatto B.","year":"1999","unstructured":"Gatto B.; Capranico G.; Palumbo M.; Drugs acting on DNA topoisomerases: Recent advances and future perspectives. Curr Pharm Des 1999,5(3),195-215","journal-title":"Curr Pharm Des"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejmech.2013.11.029","volume":"74","author":"Rescifina A.","year":"2014","unstructured":"Rescifina A.; Zagni C.; Varrica M.G.; Pistar\u00e0 V.; Corsaro A.; Recent advances in small organic molecules as DNA intercalating agents: Synthesis, activity, and modeling. Eur J Med Chem 2014,74,95-115","journal-title":"Eur J Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cbi.2018.02.013","volume":"286","author":"Calvillo-P\u00e1ez V.","year":"2018","unstructured":"Calvillo-P\u00e1ez V.; Sotelo-Mundo R.R.; Leyva-Peralta M.; G\u00e1lvez-Ruiz J.C.; Corona-Mart\u00ednez D.; Moreno-Corral R.; Escobar-Picos R.; H\u00f6pfl H.; Ju\u00e1rez-S\u00e1nchez O.; Lara K.O.; Synthesis, spectroscopic, physicochemical and structural characterization of tetrandrine-based macrocycles functionalized with acridine and anthracene groups: DNA binding and anti-proliferative activity. Chem Biol Interact 2018,286,34-44","journal-title":"Chem Biol Interact"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"7112","DOI":"10.1016\/j.bmc.2012.09.055","volume":"20","author":"Duskova K.","year":"2012","unstructured":"Duskova K.; Sierra S.; Fern\u00e1ndez M-J.; Gude L.; Lorente A.; Synthesis and DNA interaction of ethylenediamine platinum(II) complexes linked to DNA intercalants. Bioorg Med Chem 2012,20(24),7112-7118","journal-title":"Bioorg Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bmc.2017.11.044","volume":"26","author":"Hao G.","year":"2018","unstructured":"Hao G.; Sun J.; Wei C.; Studies on interactions of carbazole derivatives with DNA, cell image, and cytotoxicity. Bioorg Med Chem 2018,26(1),285-294","journal-title":"Bioorg Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejmech.2015.09.026","volume":"104","author":"Ho S-H.S.","year":"2015","unstructured":"Ho S-H.S.; Sim M-Y.; Yee W-L.S.; Yang T.; Yuen S-P.J.; Go M-L.; Antiproliferative, DNA intercalation and redox cycling activities of dioxonaphtho[2,3-d]imidazolium analogs of YM155: A structure-activity relationship study. Eur J Med Chem 2015,104,42-56","journal-title":"Eur J Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejmech.2018.06.004","volume":"155","author":"Ibrahim M.K.","year":"2018","unstructured":"Ibrahim M.K.; Taghour M.S.; Metwaly A.M.; Belal A.; Mehany A.B.M.; Elhendawy M.A.; Radwan M.M.; Yassin A.M.; El-Deeb N.M.; Hafez E.E.; ElSohly M.A.; Eissa I.H.; Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors. Eur J Med Chem 2018,155,117-134","journal-title":"Eur J Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"15525","DOI":"10.1039\/C4CC07807A","volume":"50","author":"Okuma K.","year":"2014","unstructured":"Okuma K.; Koga T.; Ozaki S.; Suzuki Y.; Horigami K.; Nagahora N.; Shioji K.; Fukuda M.; Deshimaru M.; One-pot synthesis of dibenzo[b,h][1,6]naphthyridines from 2-acetylaminobenzaldehyde: Application to a fluorescent DNA-binding compound. Chem Commun (Camb) 2014,50(98),15525-15528","journal-title":"Chem Commun (Camb)"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.talanta.2018.05.034","volume":"188","author":"Zhang Y.","year":"2018","unstructured":"Zhang Y.; Zhang Y.; Yang W.; Bian L.; Fluorescent reversible regulation based on photoinduced electron transfer from DNA to quantum dots and intercalation binding of DNA intercalator to DNA. Talanta 2018,188,7-16","journal-title":"Talanta"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ejmech.2017.09.017","volume":"140","author":"Zhang Z.","year":"2017","unstructured":"Zhang Z.; Xiao X.; Su T.; Wu J.; Ren J.; Zhu J.; Zhang X.; Cao R.; Du R.; Synthesis, structure-activity relationships and preliminary mechanism of action of novel water-soluble 4-quinolone-3-carboxamides as antiproliferative agents. Eur J Med Chem 2017,140,239-251","journal-title":"Eur J Med Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejmech.2019.05.088","volume":"178","author":"Su T.","year":"2019","unstructured":"Su T.; Zhu J.; Sun R.; Zhang H.; Huang Q.; Zhang X.; Du R.; Qiu L.; Cao R.; Design, synthesis and biological evaluation of new quinoline derivatives as potential antitumor agents. Eur J Med Chem 2019,178,154-167","journal-title":"Eur J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ejmech.2018.11.048","volume":"162","author":"Li S.","year":"2019","unstructured":"Li S.; Hu L.; Li J.; Zhu J.; Zeng F.; Huang Q.; Qiu L.; Du R.; Cao R.; Design, synthesis, structure-activity relationships and mechanism of action of new quinoline derivatives as potential antitumor agents. Eur J Med Chem 2019,162,666-678","journal-title":"Eur J Med Chem"},{"key":"ref=81","doi-asserted-by":"publisher","author":"Ribeiro A.G.","unstructured":"Ribeiro A.G.; Almeida S.M.V.; de Oliveira J.F.; Souza T.R.C.L.; Santos K.L.D.; Albuquerque A.P.B.; Nogueira M.C.B.L.; Junior, L.B. ; Moura R.O.; da Silva A.C.; Pereira V.R.A.; Castro M.C.A.B.; Lima M.D.C.A.; Novel 4-quinolinethiosemicarbazone derivatives: Synthesis, antiproliferative activity, in vitro and in silico biomacromolecule interaction studies and topoisomerase inhibition. Eur. J. Med. Chem., 2019, 182, 111, 592.","DOI":"10.1016\/j.ejmech.2019.111592"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejmech.2018.12.060","volume":"164","author":"Jafari F.","year":"2019","unstructured":"Jafari F.; Baghayi H.; Lavaee P.; Hadizadeh F.; Soltani F.; Moallemzadeh H.; Mirzaei S.; Aboutorabzadeh S.M.; Ghodsi R.; Design, synthesis and biological evaluation of novel benzo- and tetrahydrobenzo-[h]quinoline derivatives as potential DNA-intercalating antitumor agents. Eur J Med Chem 2019,164,292-303","journal-title":"Eur J Med Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejmech.2019.03.027","volume":"171","author":"Mrozek-Wilczkiewicz A.","year":"2019","unstructured":"Mrozek-Wilczkiewicz A.; Malarz K.; Rejmund M.; Polanski J.; Musiol R.; Anticancer activity of the thiosemicarbazones that are based on di-2-pyridine ketone and quinoline moiety. Eur J Med Chem 2019,171,180-194","journal-title":"Eur J Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1016\/j.ejmech.2011.07.057","volume":"46","author":"Mishra B.B.","year":"2011","unstructured":"Mishra B.B.; Tiwari V.K.; Natural products: An evolving role in future drug discovery. Eur J Med Chem 2011,46(10),4769-4807","journal-title":"Eur J Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ejmech.2014.11.021","volume":"97","author":"Xiong Y-X.","year":"2015","unstructured":"Xiong Y-X.; Huang Z-S.; Tan J-H.; Targeting G-quadruplex nucleic acids with heterocyclic alkaloids and their derivatives. Eur J Med Chem 2015,97,538-551","journal-title":"Eur J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1039\/C5OB02408K","volume":"14","author":"Le Gresley A.","year":"2016","unstructured":"Le Gresley A.; Gudivaka V.; Carrington S.; Sinclair A.; Brown J.E.; Synthesis, analysis and biological evaluation of novel indolquinonecryptolepine analogues as potential anti-tumour agents. Org Biomol Chem 2016,14(11),3069-3079","journal-title":"Org Biomol Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.1021\/acs.jmedchem.7b00016","volume":"60","author":"Zeng D-Y.","year":"2017","unstructured":"Zeng D-Y.; Kuang G-T.; Wang S-K.; Peng W.; Lin S-L.; Zhang Q.; Su X-X.; Hu M-H.; Wang H.; Tan J-H.; Huang Z-S.; Gu L-Q.; Ou T-M.; Discovery of novel 11-triazole substituted benzofuro[3,2-b]quinolone derivatives as c-myc G-quadruplex specific stabilizers via click chemistry. J Med Chem 2017,60(13),5407-5423","journal-title":"J Med Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejmech.2019.02.072","volume":"169","author":"Yuan J-M.","year":"2019","unstructured":"Yuan J-M.; Wei K.; Zhang G-H.; Chen N-Y.; Wei X-W.; Pan C-X.; Mo D-L.; Su G-F.; Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis. Eur J Med Chem 2019,169,144-158","journal-title":"Eur J Med Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/jhet.3244","volume":"55","author":"Jiang D.","year":"2018","unstructured":"Jiang D.; 4-Quinolone derivatives and their activities against gram-negative pathogens. J Heterocycl Chem 2018,55,2003-2018","journal-title":"J Heterocycl Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/jhet.3617","volume":"56","author":"Patel D.B.","year":"2019","unstructured":"Patel D.B.; Patel K.D.; Prajapati N.P.; Patel K.R.; Rajani D.P.; Rajani S.D.; Shah N.S.; Zala D.D.; Patel H.D.; Design, synthesis, and biological and in silico study of fluorine-containing quinoline hybrid thiosemicarbazide analogues. J Heterocycl Chem 2019,56,2235-2252","journal-title":"J Heterocycl Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.ejmech.2017.10.042","volume":"143","author":"Faidallah H.M.","year":"2018","unstructured":"Faidallah H.M.; Girgis A.S.; Tiwari A.D.; Honkanadavar H.H.; Thomas S.J.; Samir A.; Kalmouch A.; Alamry K.A.; Khan K.A.; Ibrahim T.S.; Al-Mahmoudy A.M.M.; Asiri A.M.; Panda S.S.; Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates. Eur J Med Chem 2018,143,1524-1534","journal-title":"Eur J Med Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.bmc.2018.05.031","volume":"26","author":"Teng P.","year":"2018","unstructured":"Teng P.; Li C.; Peng Z.; Anne Marie V.; Nimmagadda A.; Su M.; Li Y.; Sun X.; Cai J.; Facilely accessible quinoline derivatives as potent antibacterial agents. Bioorg Med Chem 2018,26(12),3573-3579","journal-title":"Bioorg Med Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"S568","DOI":"10.1016\/j.arabjc.2012.11.002","volume":"10","author":"Sharma P.C.","year":"2017","unstructured":"Sharma P.C.; Jain A.; Yar M.S.; Pahwa R.; Singh J.; Chanalia P.; Novel fluoroquinolone derivatives bearing N-thiomide linkage with 6-substituted-2-aminobenzothiazoles: Synthesis and antibacterial evaluation. Arab J Chem 2017,10,S568-S575","journal-title":"Arab J Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.bmc.2017.01.007","volume":"25","author":"Alagumuthu M.","year":"2017","unstructured":"Alagumuthu M.; Arumugam S.; Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors\/antibacterial agents. Bioorg Med Chem 2017,25(4),1448-1455","journal-title":"Bioorg Med Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.bmcl.2016.06.038","volume":"27","author":"Umamatheswari S.","year":"2017","unstructured":"Umamatheswari S.; Sankar C.; Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives. Bioorg Med Chem Lett 2017,27(3),695-699","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijid.2016.10.010","volume":"56","author":"Ansumana R.","year":"2017","unstructured":"Ansumana R.; Keitell S.; Roberts G.M.T.; Ntoumi F.; Petersen E.; Ippolito G.; Zumla A.; Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: Experiences and lessons from the 2014-2015 Ebola virus disease outbreak in West Africa. Int J Infect Dis 2017,56,101-104","journal-title":"Int J Infect Dis"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.ijmyco.2016.10.002","volume":"5","author":"Baghdadi S.","year":"2016","unstructured":"Baghdadi S.; Situational analysis of tuberculosis control programs in the Eastern Mediterranean region: Gaps and solutions. Int J Mycobacteriol 2016,5(Suppl. 1),S14","journal-title":"Int J Mycobacteriol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1128\/CMR.00055-15","volume":"29","author":"Jagielski T.","year":"2016","unstructured":"Jagielski T.; Minias A.; van Ingen J.; Rastogi N.; Brzostek A.; \u017baczek A.; Dziadek J.; Methodological and clinical aspects of the molecular epidemiology of Mycobacterium tuberculosis and other mycobacteria. Clin Microbiol Rev 2016,29(2),239-290","journal-title":"Clin Microbiol Rev"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.12968\/bjon.2011.20.17.1128","volume":"20","author":"Karim K.","year":"2011","unstructured":"Karim K.; Tuberculosis and infection control. Br J Nurs 2011,20(17),1128-, 1130-1133","journal-title":"Br J Nurs"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2217\/fmb.14.125","volume":"10","author":"Zuniga E.S.","year":"2015","unstructured":"Zuniga E.S.; Early J.; Parish T.; The future for early-stage tuberculosis drug discovery. Future Microbiol 2015,10(2),217-229","journal-title":"Future Microbiol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.2174\/1381612819666131118203915","volume":"20","author":"Tomioka H.","year":"2014","unstructured":"Tomioka H.; Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Curr Pharm Des 2014,20(27),4305-4306","journal-title":"Curr Pharm Des"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMp1314385","volume":"371","author":"Cox E.","year":"2014","unstructured":"Cox E.; Laessig K.; FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis. N Engl J Med 2014,371(8),689-691","journal-title":"N Engl J Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1586\/14787210.2015.1021785","volume":"13","author":"B\u00e9lard S.","year":"2015","unstructured":"B\u00e9lard S.; Heuvelings C.C.; Janssen S.; Grobusch M.P.; Bedaquiline for the treatment of drug-resistant tuberculosis. Expert Rev Anti Infect Ther 2015,13(5),535-553","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/resp.13143","volume":"23","author":"Dheda K.","year":"2018","unstructured":"Dheda K.; Cox H.; Esmail A.; Wasserman S.; Chang K.C.; Lange C.; Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB? Respirology 2018,23(1),36-45","journal-title":"Respirology"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bmcl.2014.12.040","volume":"25","author":"Surineni G.","year":"2015","unstructured":"Surineni G.; Yogeeswari P.; Sriram D.; Kantevari S.; Design and synthesis of novel carbazole tethered pyrrole derivatives as potent inhibitors of Mycobacterium tuberculosis. Bioorg Med Chem Lett 2015,25(3),485-491","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1016\/j.bmcl.2016.04.088","volume":"26","author":"Pulipati L.","year":"2016","unstructured":"Pulipati L.; Sridevi J.P.; Yogeeswari P.; Sriram D.; Kantevari S.; Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides. Bioorg Med Chem Lett 2016,26(13),3135-3140","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1007\/s00044-014-1210-y","volume":"24","author":"Surineni G.","year":"2015","unstructured":"Surineni G.; Yogeeswari P.; Sriram D.; Kantevari S.; Rational design, synthesis and evaluation of novel-substituted 1,2,3-triazolylmethyl carbazoles as potent inhibitors of Mycobacterium tuberculosis. Med Chem Res 2015,24,1298-1309","journal-title":"Med Chem Res"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S1473-3099(03)00671-6","volume":"3","author":"Ginsburg A.S.","year":"2003","unstructured":"Ginsburg A.S.; Grosset J.H.; Bishai W.R.; Fluoroquinolones, tuberculosis, and resistance. Lancet Infect Dis 2003,3(7),432-442","journal-title":"Lancet Infect Dis"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejmech.2018.12.043","volume":"164","author":"Marvadi S.K.","year":"2019","unstructured":"Marvadi S.K.; Krishna V.S.; Sriram D.; Kantevari S.; Synthesis of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines as potent inhibitors of Mycobacterium tuberculosis. Eur J Med Chem 2019,164,171-178","journal-title":"Eur J Med Chem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bmcl.2018.11.002","volume":"29","author":"Shruthi T.G.","year":"2019","unstructured":"Shruthi T.G.; Eswaran S.; Shivarudraiah P.; Narayanan S.; Subramanian S.; Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety. Bioorg Med Chem Lett 2019,29(1),97-102","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.126671","volume":"29","author":"Ramprasad J.","year":"2019","unstructured":"Ramprasad J.; Kumar Sthalam V.; Linga Murthy Thampunuri R.; Bhukya S.; Ummanni R.; Balasubramanian S.; Pabbaraja S.; Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach. Bioorg Med Chem Lett 2019,29(20)","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bmcl.2019.01.004","volume":"29","author":"Marvadi S.K.","year":"2019","unstructured":"Marvadi S.K.; Krishna V.S.; Sriram D.; Kantevari S.; Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents. Bioorg Med Chem Lett 2019,29(4),529-533","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1016\/j.bmcl.2019.07.040","volume":"29","author":"Marvadi S.K.","year":"2019","unstructured":"Marvadi S.K.; Krishna V.S.; Sinegubova E.O.; Volobueva A.S.; Esaulkova Y.L.; Muryleva A.A.; Tentler D.G.; Sriram D.; Zarubaev V.V.; Kantevari S.; 5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation. Bioorg Med Chem Lett 2019,29(18),2664-2669","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1016\/j.bmc.2019.06.002","volume":"27","author":"Santoso K.T.","year":"2019","unstructured":"Santoso K.T.; Menorca A.; Cheung C-Y.; Cook G.M.; Stocker B.L.; Timmer M.S.M.; The synthesis and evaluation of quinolinequinones as anti-mycobacterial agents. Bioorg Med Chem 2019,27(16),3532-3545","journal-title":"Bioorg Med Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.amjmed.2007.04.005","volume":"120","author":"Majithia V.","year":"2007","unstructured":"Majithia V.; Geraci S.A.; Rheumatoid arthritis: Diagnosis and management. Am J Med 2007,120(11),936-939","journal-title":"Am J Med"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cell.2014.01.025","volume":"156","author":"Heintz C.","year":"2014","unstructured":"Heintz C.; Mair W.; You are what you host: Microbiome modulation of the aging process. Cell 2014,156(3),408-411","journal-title":"Cell"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/JCM.01283-12","volume":"50","author":"Lockhart S.R.","year":"2012","unstructured":"Lockhart S.R.; Iqbal N.; Cleveland A.A.; Farley M.M.; Harrison L.H.; Bolden C.B.; Baughman W.; Stein B.; Hollick R.; Park B.J.; Chiller T.; Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol 2012,50(11),3435-3442","journal-title":"J Clin Microbiol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3410\/M3-14","volume":"3","author":"Low C-Y.","year":"2011","unstructured":"Low C-Y.; Rotstein C.; Emerging fungal infections in immunocompromised patients. F1000 Med Rep 2011,3,14","journal-title":"F1000 Med Rep"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00277-013-1867-1","volume":"93","author":"Mousset S.","year":"2014","unstructured":"Mousset S.; Buchheidt D.; Heinz W.; Ruhnke M.; Cornely O.A.; Egerer G.; Kr\u00fcger W.; Link H.; Neumann S.; Ostermann H.; Panse J.; Penack O.; Rieger C.; Schmidt-Hieber M.; Silling G.; S\u00fcdhoff T.; Ullmann A.J.; Wolf H-H.; Maschmeyer G.; B\u00f6hme A.; Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2014,93(1),13-32","journal-title":"Ann Hematol"},{"key":"ref=120","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2373424","volume":"2016","author":"Kaur R.","year":"2016","unstructured":"Kaur R.; Dhakad M.S.; Goyal R.; Bhalla P.; Dewan R.; Spectrum of opportunistic fungal infections in HIV\/AIDS patients in ertiary Care hospital in India. Can J Infect Dis Med Microbiol 2016,2016","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-3-319-04220-6_4","author":"Angarone M.","year":"2014","unstructured":"Angarone M.; Fungal infections in cancer patients Infectious Complications in Cancer Patients; Stosor, V 2014,129-155","journal-title":"Fungal infections in cancer patients Infectious Complications in Cancer Patients; Stosor, V"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jinf.2017.09.011","volume":"75","author":"Economides M.P.","year":"2017","unstructured":"Economides M.P.; Ballester L.Y.; Kumar V.A.; Jiang Y.; Tarrand J.; Prieto V.; Torres H.A.; Kontoyiannis D.P.; Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000-2016): Uncommon, with improved survival but still deadly often. J Infect 2017,75(6),572-580","journal-title":"J Infect"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jmii.2010.08.010","volume":"44","author":"Chi H-W.","year":"2011","unstructured":"Chi H-W.; Yang Y-S.; Shang S-T.; Chen K-H.; Yeh K-M.; Chang F-Y.; Lin J-C.; Candida albicans versus non-albicans bloodstream infections: The comparison of risk factors and outcome. J Microbiol Immunol Infect 2011,44(5),369-375","journal-title":"J Microbiol Immunol Infect"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","volume":"7","author":"Whaley S.G.","year":"2017","unstructured":"Whaley S.G.; Berkow E.L.; Rybak J.M.; Nishimoto A.T.; Barker K.S.; Rogers P.D.; Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol 2017,7,2173","journal-title":"Front Microbiol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrd.2017.46","volume":"16","author":"Perfect J.R.","year":"2017","unstructured":"Perfect J.R.; The antifungal pipeline: A reality check. Nat Rev Drug Discov 2017,16(9),603-616","journal-title":"Nat Rev Drug Discov"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1101\/cshperspect.a019703","volume":"4","author":"Roemer T.","year":"2014","unstructured":"Roemer T.; Krysan D.J.; Antifungal drug development: Challenges, unmet clinical needs, and new approaches. Cold Spring Harb Perspect Med 2014,4(5),4","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bmcl.2019.01.006","volume":"29","author":"Villa P.","year":"2019","unstructured":"Villa P.; Arumugam N.; Almansour A.I.; Suresh Kumar R.; Mahalingam S.M.; Maruoka K.; Thangamani S.; Benzimidazole tethered pyrrolo[3,4-b]quinoline with broad-spectrum activity against fungal pathogens. Bioorg Med Chem Lett 2019,29(5),729-733","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.bmc.2019.02.009","volume":"27","author":"Sun B.","year":"2019","unstructured":"Sun B.; Dong Y.; Lei K.; Wang J.; Zhao L.; Liu M.; Design, synthesis and biological evaluation of amide-pyridine derivatives as novel dual-target (SE, CYP51) antifungal inhibitors. Bioorg Med Chem 2019,27(12),2427-2437","journal-title":"Bioorg Med Chem"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.ejmech.2017.10.043","volume":"143","author":"Liu N.","year":"2018","unstructured":"Liu N.; Zhong H.; Tu J.; Jiang Z.; Jiang Y.; Jiang Y.; Jiang Y.; Li J.; Zhang W.; Wang Y.; Sheng C.; Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors. Eur J Med Chem 2018,143,1510-1523","journal-title":"Eur J Med Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ejmech.2017.01.043","volume":"128","author":"Shaikh S.K.J.","year":"2017","unstructured":"Shaikh S.K.J.; Kamble R.R.; Somagond S.M.; Devarajegowda H.C.; Dixit S.R.; Joshi S.D.; Tetrazolylmethyl quinolines: Design, docking studies, synthesis, anticancer and antifungal analyses. Eur J Med Chem 2017,128,258-273","journal-title":"Eur J Med Chem"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1475-2875-10-144","volume":"10","author":"Achan J.","year":"2011","unstructured":"Achan J.; Talisuna A.O.; Erhart A.; Yeka A.; Tibenderana J.K.; Baliraine F.N.; Rosenthal P.J.; D\u2019Alessandro U.; Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria. Malar J 2011,10,144","journal-title":"Malar J"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jama.1946.02870160015006","volume":"130","author":"Loeb F.","year":"1946","unstructured":"Loeb F.; Clark W.M.; Coatney G.R.; Coggeshall L.T.; Dieuaide F.R.; Dochez A.R.; Hakansson E.G.; Marshall E.K.; Marvel C.S.; McCoy O.R.; Sapero J.J.; Sebrell W.H.; Shannon J.A.; Carden G.A.; Activity of a new antimalarial agent, Chloroquine (SN 7618): Statement approved by the Board for Coordination of Malarial Studies. JAMA 1946,130,1069-1070","journal-title":"JAMA"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejmech.2014.11.022","volume":"90","author":"Mushtaque M.","year":"2015","unstructured":"Mushtaque M.; Shahjahan, Reemergence of chloroquine (CQ) analogs as multi-targeting antimalarial agents: A review. Eur J Med Chem 2015,90,280-295","journal-title":"Eur J Med Chem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4269\/ajtmh.1986.35.711","volume":"35","author":"Brasseur P.","year":"1986","unstructured":"Brasseur P.; Druilhe P.; Kouamouo J.; Brandicourt O.; Danis M.; Moyou S.R.; High level of sensitivity to chloroquine of 72 Plasmodium falciparum isolates from southern Cameroon in January 1985. Am J Trop Med Hyg 1986,35(4),711-716","journal-title":"Am J Trop Med Hyg"},{"key":"ref=135","first-page":"15","volume":"27","author":"Bunnag D.","year":"1996","unstructured":"Bunnag D.; Karbwang J.; Na-Bangchang K.; Thanavibul A.; Chittamas S.; Harinasuta T.; Quinine-tetracycline for multidrug resistant falciparum malaria. Southeast Asian J Trop Med Public Health 1996,27(1),15-18","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S1473-3099(15)00148-6","volume":"15","author":"Wells T.N.","year":"2015","unstructured":"Wells T.N.; Hooft van Huijsduijnen R.; Ferroquine: Welcome to the next generation of antimalarials. Lancet Infect Dis 2015,15(12),1365-1366","journal-title":"Lancet Infect Dis"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/S1473-3099(15)00079-1","volume":"15","author":"Held J.","year":"2015","unstructured":"Held J.; Supan C.; Salazar C.L.; Tinto H.; Bonkian L.N.; Nahum A.; Moulero B.; Si\u00e9 A.; Coulibaly B.; Sirima S.B.; Siribie M.; Otsyula N.; Otieno L.; Abdallah A.M.; Kimutai R.; Bouyou-Akotet M.; Kombila M.; Koiwai K.; Cantalloube C.; Din-Bell C.; Djeriou E.; Waitumbi J.; Mordm\u00fcller B.; Ter-Minassian D.; Lell B.; Kremsner P.G.; Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: A phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study. Lancet Infect Dis 2015,15(12),1409-1419","journal-title":"Lancet Infect Dis"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejmech.2019.06.023","volume":"179","author":"Stringer T.","year":"2019","unstructured":"Stringer T.; Wiesner L.; Smith G.S.; Ferroquine-derived polyamines that target resistant Plasmodium falciparum. Eur J Med Chem 2019,179,78-83","journal-title":"Eur J Med Chem"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejmech.2019.02.012","volume":"167","author":"AlFadly E.D.","year":"2019","unstructured":"AlFadly E.D.; Elzahhar P.A.; Tramarin A.; Elkazaz S.; Shaltout H.; Abu-Serie M.M.; Janockova J.; Soukup O.; Ghareeb D.A.; El-Yazbi A.F.; Rafeh R.W.; Bakkar N.Z.; Kobeissy F.; Iriepa I.; Moraleda I.; Saudi M.N.S.; Bartolini M.; Belal A.S.F.; Tackling neuroinflammation and cholinergic deficit in Alzheimer\u2019s disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase. Eur J Med Chem 2019,167,161-186","journal-title":"Eur J Med Chem"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.bmc.2019.01.044","volume":"27","author":"da Silva R.M.R.J.","year":"2019","unstructured":"da Silva R.M.R.J.; Gandi M.O.; Mendon\u00e7a J.S.; Carvalho A.S.; Coutinho J.P.; Aguiar A.C.C.; Krettli A.U.; Boechat N.; New hybrid trifluoromethylquinolines as antiplasmodium agents. Bioorg Med Chem 2019,27(6),1002-1008","journal-title":"Bioorg Med Chem"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejmech.2017.11.033","volume":"143","author":"Rani A.","year":"2018","unstructured":"Rani A.; Singh A.; Gut J.; Rosenthal P.J.; Kumar V.; Microwave-promoted facile access to 4-aminoquinoline-phthalimides: Synthesis and anti-plasmodial evaluation. Eur J Med Chem 2018,143,150-156","journal-title":"Eur J Med Chem"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejmech.2018.02.021","volume":"148","author":"Chopra R.","year":"2018","unstructured":"Chopra R.; Chibale K.; Singh K.; Pyrimidine-chloroquinoline hybrids: Synthesis and antiplasmodial activity. Eur J Med Chem 2018,148,39-53","journal-title":"Eur J Med Chem"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejmech.2018.08.063","volume":"158","author":"Bonilla-Ramirez L.","year":"2018","unstructured":"Bonilla-Ramirez L.; Rios A.; Quiliano M.; Ramirez-Calderon G.; Beltr\u00e1n-Hortelano I.; Franetich J.F.; Corcuera L.; Bordessoulles M.; Vettorazzi A.; L\u00f3pez de Cerain A.; Aldana I.; Mazier D.; Pab\u00f3n A.; Galiano S.; Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies. Eur J Med Chem 2018,158,68-81","journal-title":"Eur J Med Chem"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neuroscience.2014.09.061","volume":"302","author":"Latta C.H.","year":"2015","unstructured":"Latta C.H.; Brothers H.M.; Wilcock D.M.; Neuroinflammation in Alzheimer\u2019s disease; A source of heterogeneity and target for personalized therapy. Neuroscience 2015,302,103-111","journal-title":"Neuroscience"},{"key":"ref=145","volume":"3","author":"Arevalo-Rodriguez I.","year":"2015","unstructured":"Arevalo-Rodriguez I.; Smailagic N.; Roqu\u00e9 I.; Figuls, M.; Ciapponi, A.; Sanchez-Perez, E.; Giannakou, A.; Pedraza, O.L.; Bonfill Cosp, X.; Cullum, S. Mini-mental state examination (MMSE) for the detection of Alzheimer\u2019s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2015,3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.bbr.2009.12.044","volume":"221","author":"Contestabile A.","year":"2011","unstructured":"Contestabile A.; The history of the cholinergic hypothesis. Behav Brain Res 2011,221(2),334-340","journal-title":"Behav Brain Res"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.pbb.2011.02.022","volume":"99","author":"Dumas J.A.","year":"2011","unstructured":"Dumas J.A.; Newhouse P.A.; The cholinergic hypothesis of cognitive aging revisited again: Cholinergic functional compensation. Pharmacol Biochem Behav 2011,99(2),254-261","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.neubiorev.2011.03.001","volume":"35","author":"Craig L.A.","year":"2011","unstructured":"Craig L.A.; Hong N.S.; McDonald R.J.; Revisiting the cholinergic hypothesis in the development of Alzheimer\u2019s disease. Neurosci Biobehav Rev 2011,35(6),1397-1409","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/cmdc.201600014","volume":"11","author":"Prati F.","year":"2016","unstructured":"Prati F.; Bergamini C.; Fato R.; Soukup O.; Korabecny J.; Andrisano V.; Bartolini M.; Bolognesi M.L.; Novel 8-hydroxyquinoline derivatives as multitarget compounds for the treatment of Alzheimer\u2019s disease. ChemMedChem 2016,11(12),1284-1295","journal-title":"ChemMedChem"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejmech.2019.02.021","volume":"168","author":"Chalupova K.","year":"2019","unstructured":"Chalupova K.; Korabecny J.; Bartolini M.; Monti B.; Lamba D.; Caliandro R.; Pesaresi A.; Brazzolotto X.; Gastellier A-J.; Nachon F.; Pejchal J.; Jarosova M.; Hepnarova V.; Jun D.; Hrabinova M.; Dolezal R.; Zdarova Karasova J.; Mzik M.; Kristofikova Z.; Misik J.; Muckova L.; Jost P.; Soukup O.; Benkova M.; Setnicka V.; Habartova L.; Chvojkova M.; Kleteckova L.; Vales K.; Mezeiova E.; Uliassi E.; Valis M.; Nepovimova E.; Bolognesi M.L.; Kuca K.; Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer\u2019s disease. Eur J Med Chem 2019,168,491-514","journal-title":"Eur J Med Chem"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.bmcl.2019.03.050","volume":"29","author":"Zhu J.","year":"2019","unstructured":"Zhu J.; Wang L-N.; Cai R.; Geng S-Q.; Dong Y-F.; Liu Y-M.; Design, synthesis, evaluation and molecular modeling study of 4-N-phenylaminoquinolines for Alzheimer disease treatment. Bioorg Med Chem Lett 2019,29(11),1325-1329","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bmc.2019.115190","volume":"28","author":"Luo W.","year":"2020","unstructured":"Luo W.; Lv J-W.; Wang T.; Zhang Z-Y.; Guo H-Y.; Song Z-Y.; Wang C-J.; Ma J.; Chen Y.P.; Synthesis, in vitro and in vivo biological evaluation of novel graveolinine derivatives as potential anti-Alzheimer agents. Bioorg Med Chem 2020,28(1),115-190","journal-title":"Bioorg Med Chem"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ejmech.2018.06.044","volume":"155","author":"Chioua M.","year":"2018","unstructured":"Chioua M.; Buzzi E.; Moraleda I.; Iriepa I.; Maj M.; Wnorowski A.; Giovannini C.; Tramarin A.; Portali F.; Ismaili L.; L\u00f3pez-Alvarado P.; Bolognesi M.L.; J\u00f3\u017awiak K.; Men\u00e9ndez J.C.; Marco-Contelles J.; Bartolini M.; Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer\u2019s disease. Eur J Med Chem 2018,155,839-846","journal-title":"Eur J Med Chem"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1016\/j.bmc.2018.10.003","volume":"26","author":"Lopes J.P.B.","year":"2018","unstructured":"Lopes J.P.B.; Silva L.; da Costa Franarin G.; Antonio Ceschi M.; Seibert L\u00fcdtke D.; Ferreira Dantas R.; de Salles C.M.C.; Paes Silva-Jr F.; Roberto Senger M.; Alvim Guedes I.; Emmanuel Dardenne L.; Design, synthesis, cholinesterase inhibition and molecular modelling study of novel tacrine hybrids with carbohydrate derivatives. Bioorg Med Chem 2018,26(20),5566-5577","journal-title":"Bioorg Med Chem"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1146\/annurev.bi.57.070188.004033","volume":"57","author":"Rademacher T.W.","year":"1988","unstructured":"Rademacher T.W.; Parekh R.B.; Dwek R.A.; Glycobiology. Annu Rev Biochem 1988,57,785-838","journal-title":"Annu Rev Biochem"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1021\/ar400132g","volume":"47","author":"Mohan S.","year":"2014","unstructured":"Mohan S.; Eskandari R.; Pinto B.M.; Naturally occurring sulfonium-ion glucosidase inhibitors and their derivatives: A promising class of potential antidiabetic agents. Acc Chem Res 2014,47(1),211-225","journal-title":"Acc Chem Res"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1021\/jm500907a","volume":"58","author":"Maccari R.","year":"2015","unstructured":"Maccari R.; Ottan\u00e0 R.; Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: New insights and future directions. J Med Chem 2015,58(5),2047-2067","journal-title":"J Med Chem"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2174\/156800911795655958","volume":"11","author":"Tammali R.","year":"2011","unstructured":"Tammali R.; Srivastava S.K.; Ramana K.V.; Targeting aldose reductase for the treatment of cancer. Curr Cancer Drug Targets 2011,11(5),560-571","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=159","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2019.115263","volume":"28","author":"Dowarah J.","year":"2020","unstructured":"Dowarah J.; Singh V.P.; Anti-diabetic drugs recent approaches and advancements. Bioorg Med Chem 2020,28(5)","journal-title":"Bioorg Med Chem"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1016\/j.bmc.2019.07.035","volume":"27","author":"Taha M.","year":"2019","unstructured":"Taha M.; Sultan S.; Imran S.; Rahim F.; Zaman K.; Wadood A.; Ur Rehman A.; Uddin N.; Mohammed Khan K.; Synthesis of quinoline derivatives as diabetic II inhibitors and molecular docking studies. Bioorg Med Chem 2019,27(18),4081-4088","journal-title":"Bioorg Med Chem"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejmech.2018.04.015","volume":"152","author":"Crespo I.","year":"2018","unstructured":"Crespo I.; Gim\u00e9nez-Dejoz J.; Port\u00e9 S.; Cousido-Siah A.; Mitschler A.; Podjarny A.; Pratsinis H.; Kletsas D.; Par\u00e9s X.; Ruiz F.X.; Metwally K.; Farr\u00e9s J.; Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase. Eur J Med Chem 2018,152,160-174","journal-title":"Eur J Med Chem"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557520999201214234735","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/189141\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557520999201214234735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T09:01:15Z","timestamp":1697360475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/189141\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":161,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557520999201214234735","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-06-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}